SELLAS Life Sciences Group Inc (SLS)

0.92 +0.02 (+2.15%) USD  |  NASDAQ  |  Dec 23, 14:47
More

SELLAS Life Sciences Group Max Drawdown (5Y): 100.00% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Microbot Medical Inc 99.78%
Alaunos Therapeutics Inc 99.76%
Galectin Therapeutics Inc 88.76%
Oragenics Inc 99.70%
Anavex Life Sciences Corp 88.25%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -58.83
Beta (5Y) 2.391
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 129.7%
Historical Sharpe Ratio (5Y) -0.2073
Historical Sortino (5Y) -0.4954
Monthly Value at Risk (VaR) 5% (5Y Lookback) 45.03%